{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T05:29:43Z","timestamp":1795066183279,"version":"4.10.2"},"reference-count":62,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Centre of Excellence"},{"DOI":"10.13039\/100006662","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012317","name":"UCLH BRC","doi-asserted-by":"publisher","award":["BRC 525 III\/CC 101350"],"award-info":[{"award-number":["BRC 525 III\/CC 101350"]}],"id":[{"id":"10.13039\/501100012317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The aetiology of primary chronic pain syndromes (CPS) is highly disputed. We performed a systematic review and meta-analysis aiming to assess differences in circulating cytokine levels in patients with diffuse CPS (fibromyalgia) vs healthy controls (HC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Human studies published in English from the PubMed, MEDLINE\/Scopus and Cochrane databases were systematically searched from inception up to January 2020. We included full text cross-sectional or longitudinal studies with baseline cytokine measurements, reporting differences in circulating cytokine levels between fibromyalgia patients and HC. Random-effects meta-analysis models were used to report pooled effects and 95% CIs. This study is registered with PROSPERO (CRD42020193774).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our initial search yielded 324 papers and identified 29 studies (2458 participants) eligible for systematic review and 22 studies (1772 participants) suitable for meta-analysis. The systematic analysis revealed reproducible findings supporting different trends of cytokine levels when fibromyalgia patients were compared with HC, while the chemokine eotaxin, was consistently raised in fibromyalgia. Meta-analysis showed significantly increased TNF-\u03b1 [standardized mean difference (SMD) = 0.36, 95% CI: 0.12, 0.60, P\u2009=\u20090.0034; I2\u2009=\u200971%, Q2P\u2009=\u20090.0002], IL-6 (SMD\u2009=\u20090.15, 95% CI: 0.003, 0.29, P\u2009=\u20090.045; I2\u2009=\u200939%, Q2P\u2009=\u20090.059), IL-8 (SMD\u2009=\u20090.26, 95% CI: 0.05, 0.47, P\u2009=\u20090.01; I2\u2009=\u200961%, Q2P\u2009=\u20090.005) and IL-10 (SMD\u2009=\u20090.61, 95% CI: 0.34, 0.89, P\u2009&amp;lt;\u20090.001; I2\u2009=\u200910%, Q2P\u2009=\u20090.34) in fibromyalgia patients compared with HC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We found evidence of significant differences in the peripheral blood cytokine profiles of fibromyalgia patients compared with HC. However, the distinctive profile associated with fibromyalgia includes both pro-inflammatory (TNF-\u03b1, IL-6, IL-8) and anti-inflammatory (IL-10) cytokines in pooled analysis, as well as chemokine (eotaxin) signatures. Further research is required to elucidate the role of cytokines in fibromyalgia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab146","type":"journal-article","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T16:45:41Z","timestamp":1612802741000},"page":"2602-2614","source":"Crossref","is-referenced-by-count":142,"title":["Is fibromyalgia associated with a unique cytokine profile? A systematic review and meta-analysis"],"prefix":"10.1093","volume":"60","author":[{"given":"Luke Furtado","family":"O\u2019Mahony","sequence":"first","affiliation":[{"name":"University College London Medical School, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnav","family":"Srivastava","sequence":"additional","affiliation":[{"name":"University College London Medical School, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9459-9306","authenticated-orcid":false,"given":"Puja","family":"Mehta","sequence":"additional","affiliation":[{"name":"Centre for Inflammation and Tissue Repair, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8911-4113","authenticated-orcid":false,"given":"Coziana","family":"Ciurtin","sequence":"additional","affiliation":[{"name":"Centre for Adolescent Rheumatology Versus Arthritis, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,2,12]]},"reference":[{"key":"2021061821282378500_keab146-B1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-88-470-2258-4_2","article-title":"Neurochemistry of pain circuits: physiological versus pathological pain","volume-title":"Neuroscience: Focus on Acute and Chronic Pain","author":"Calz\u00e1","year":"2001"},{"key":"2021061821282378500_keab146-B2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-3-319-64922-1_4","article-title":"Mechanisms of pathologic pain","volume-title":"Fundamentals of Pain Medicine","author":"Cheng","year":"2018"},{"key":"2021061821282378500_keab146-B3","doi-asserted-by":"crossref","first-page":"e010364","DOI":"10.1136\/bmjopen-2015-010364","article-title":"Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies","volume":"6","author":"Fayaz","year":"2016","journal-title":"BMJ Open"},{"key":"2021061821282378500_keab146-B4","author":"Wells","year":"2014"},{"key":"2021061821282378500_keab146-B5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/jama.279.5.381","article-title":"Epidemiology of tension-type headache","volume":"279","author":"Schwartz","year":"1998","journal-title":"JAMA"},{"key":"2021061821282378500_keab146-B6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/35093019","article-title":"Molecular mechanisms of nociception","volume":"413","author":"Julius","year":"2001","journal-title":"Nature"},{"key":"2021061821282378500_keab146-B7","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.pain.2010.09.030","article-title":"Central sensitization: implications for the diagnosis and treatment of pain","volume":"152","author":"Woolf","year":"2011","journal-title":"Pain"},{"key":"2021061821282378500_keab146-B8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nri3621","article-title":"Pathological pain and the neuroimmune interface","volume":"14","author":"Grace","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"2021061821282378500_keab146-B9","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1523\/JNEUROSCI.2619-16.2016","article-title":"Histological underpinnings of grey matter changes in fibromyalgia investigated using multimodal brain imaging","volume":"37","author":"Pomares","year":"2017","journal-title":"J Neurosci"},{"key":"2021061821282378500_keab146-B10","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neuroscience.2016.06.006","article-title":"Neurobiology of fibromyalgia and chronic widespread pain","volume":"338","author":"Sluka","year":"2016","journal-title":"Neuroscience"},{"key":"2021061821282378500_keab146-B11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","article-title":"Cytokines, inflammation and pain","volume":"45","author":"Zhang","year":"2007","journal-title":"Int Anesthesiol Clin"},{"key":"2021061821282378500_keab146-B12","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1111\/j.1468-1331.2007.01831.x","article-title":"Headache and chronic pain syndromes: the case-based guide to targeted assessment and treatment","volume":"14","author":"Jellinger","year":"2007","journal-title":"Eur J Neurol"},{"key":"2021061821282378500_keab146-B13","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins"},{"key":"2021061821282378500_keab146-B14","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res"},{"key":"2021061821282378500_keab146-B62","article-title":"How to Calculate Effect Sizes from Published Research Articles: A Simplified Methodology","author":"Thalheimer","year":"2002","journal-title":"Work-Learning Research"},{"key":"2021061821282378500_keab146-B15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jneuroim.2011.10.013","article-title":"Evidence of central inflammation in fibromyalgia\u2014increased cerebrospinal fluid interleukin-8 levels","volume":"242","author":"Kadetoff","year":"2012","journal-title":"J Neuroimmunol"},{"key":"2021061821282378500_keab146-B16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/1471-2474-12-245","article-title":"Systematic review with meta-analysis: cytokines in fibromyalgia syndrome","volume":"12","author":"\u00dc\u00e7eyler","year":"2011","journal-title":"BMC Musculoskelet Disord"},{"key":"2021061821282378500_keab146-B17","first-page":"225","article-title":"Cytokine patterns in fibromyalgia and their correlation with clinical manifestations","volume":"25","author":"Bazzichi","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"2021061821282378500_keab146-B18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10067-009-1318-5","article-title":"Low plasma levels of monocyte chemoattractant protein-1 (MCP-1), tumor necrosis factor-alpha (TNF\u03b1), and vascular endothelial growth factor (VEGF) in patients with alpha1-antitrypsin deficiency-related fibromyalgia","volume":"29","author":"Blanco","year":"2010","journal-title":"Clin Rheumatol"},{"key":"2021061821282378500_keab146-B19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000341664","article-title":"Inflammatory\/stress feedback dysregulation in women with fibromyalgia","volume":"19","author":"Bote","year":"2012","journal-title":"Neuroimmunomodulation"},{"key":"2021061821282378500_keab146-B20","doi-asserted-by":"crossref","first-page":"e74524","DOI":"10.1371\/journal.pone.0074524","article-title":"Fibromyalgia: anti-inflammatory and stress responses after acute moderate exercise","volume":"8","author":"Bote","year":"2013","journal-title":"PLoS One"},{"key":"2021061821282378500_keab146-B21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ebiom.2019.07.031","article-title":"Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgia","volume":"46","author":"Clos-Garcia","year":"2019","journal-title":"EBioMedicine"},{"key":"2021061821282378500_keab146-B22","doi-asserted-by":"crossref","first-page":"3985154","DOI":"10.1155\/2018\/3985154","article-title":"Plasma cytokine levels in fibromyalgia and their response to 15 weeks of progressive resistance exercise or relaxation therapy","volume":"2018","author":"Ernberg","year":"2018","journal-title":"Mediators Inflamm"},{"key":"2021061821282378500_keab146-B23","doi-asserted-by":"crossref","first-page":"7257681","DOI":"10.1155\/2018\/7257681","article-title":"Elevated levels of eotaxin-2 in serum of fibromyalgia patients","volume":"2018","author":"Furer","year":"2018","journal-title":"Pain Res Manag"},{"key":"2021061821282378500_keab146-B24","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1177\/0004563213506413","article-title":"Altered profile of chemokines in fibromyalgia patients","volume":"51","author":"Garc\u00eda","year":"2014","journal-title":"Ann Clin Biochem"},{"key":"2021061821282378500_keab146-B25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3233\/BMR-150610","article-title":"Evaluating relationship in cytokines level, fibromyalgia impact questionnaire and body mass index in women with fibromyalgia syndrome","volume":"29","author":"Ghizal","year":"2016","journal-title":"J Back Musculoskelet Rehabil"},{"key":"2021061821282378500_keab146-B26","first-page":"753","article-title":"Regional cerebral blood flow and cytokines in young females with fibromyalgia","volume":"20","author":"Gur","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"2021061821282378500_keab146-B27","first-page":"358","article-title":"Cytokines and depression in cases with fibromyalgia","volume":"29","author":"G\u00fcr","year":"2002","journal-title":"J Rheumatol"},{"key":"2021061821282378500_keab146-B28","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1756-0500-3-156","article-title":"Proinflammatory cytokine levels in fibromyalgia patients are independent of body mass index","volume":"3","author":"Hernandez","year":"2010","journal-title":"BMC Res Notes"},{"key":"2021061821282378500_keab146-B29","first-page":"S71","article-title":"Arterial stiffness and proinflammatory cytokines in fibromyalgia syndrome","volume":"28","author":"Kim","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"2021061821282378500_keab146-B30","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0306-4530(98)00087-0","article-title":"The immune-inflammatory pathophysiology of fibromyalgia: increased serum soluble gp130, the common signal transducer protein of various neurotrophic cytokines","volume":"24","author":"Maes","year":"1999","journal-title":"Psychoneuroendocrinology"},{"key":"2021061821282378500_keab146-B31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jneuroim.2015.11.011","article-title":"IL-8 and IL-6 primarily mediate the inflammatory response in fibromyalgia patients","volume":"290","author":"Mendieta","year":"2016","journal-title":"J Neuroimmunol"},{"key":"2021061821282378500_keab146-B32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1590\/2359-3997000000248","article-title":"Serum levels of leptin and adiponectin and clinical parameters in women with fibromyalgia and overweight\/obesity","volume":"61","author":"Paiva","year":"2017","journal-title":"Arch Endocrinol Metab"},{"key":"2021061821282378500_keab146-B33","first-page":"115","article-title":"Evaluation of vascular injury with proinflammatory cytokines, thrombomodulin and fibronectin in patients with primary fibromyalgia","volume":"63","author":"Pay","year":"2000","journal-title":"Nagoya J Med Sci"},{"key":"2021061821282378500_keab146-B34","first-page":"S60","article-title":"Increased levels of IL-17A in patients with fibromyalgia","volume":"31","author":"Pernambuco","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"2021061821282378500_keab146-B35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cyto.2016.05.011","article-title":"Evaluation of cytokines, oxidative stress markers and brain-derived neurotrophic factor in patients with fibromyalgia \u2013 A controlled cross-sectional study","volume":"84","author":"Ranzolin","year":"2016","journal-title":"Cytokine"},{"key":"2021061821282378500_keab146-B36","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12944-017-0505-7","article-title":"Alterations of anti-inflammatory lipids in plasma from women with chronic widespread pain \u2013 a case control study","volume":"16","author":"Stensson","year":"2017","journal-title":"Lipids Health Dis"},{"key":"2021061821282378500_keab146-B37","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3181\/0808-RM-254","article-title":"Plasma cytokine fluctuations over time in healthy controls and patients with fibromyalgia","volume":"234","author":"Togo","year":"2009","journal-title":"Exp Biol Med (Maywood)"},{"key":"2021061821282378500_keab146-B38","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.clinbiochem.2011.01.011","article-title":"Asymmetric dimethylarginine (ADMA) levels are increased in patients with fibromyalgia: correlation with tumor necrosis factor-\u03b1 (TNF-\u03b1) and 8-iso-prostaglandin F2\u03b1 (8-iso-PGF2\u03b1)","volume":"44","author":"Topal","year":"2011","journal-title":"Clin Biochem"},{"key":"2021061821282378500_keab146-B39","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1124\/jpet.115.230060","article-title":"Neuropeptides CRH, SP, HK-1, and inflammatory cytokines IL-6 and TNF are increased in serum of patients with fibromyalgia syndrome, implicating mast cells","volume":"356","author":"Tsilioni","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"2021061821282378500_keab146-B40","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/anr.1780321024","article-title":"Cytokines and immune regulation in patients with fibrositis","volume":"32","author":"Wallace","year":"1989","journal-title":"Arthritis Rheum"},{"key":"2021061821282378500_keab146-B41","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/rheumatology\/40.7.743","article-title":"Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study","volume":"40","author":"Wallace","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"2021061821282378500_keab146-B42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/AJP.0b013e31817e13a3","article-title":"The role of IL-8 in patients with fibromyalgia: a prospective longitudinal study of 6 months","volume":"25","author":"Wang","year":"2009","journal-title":"Clin J Pain"},{"key":"2021061821282378500_keab146-B43","first-page":"1366","article-title":"Circulating cytokine levels compared to pain in patients with fibromyalgia \u2013 a prospective longitudinal study over 6 months","volume":"35","author":"Wang","year":"2008","journal-title":"J Rheumatol"},{"key":"2021061821282378500_keab146-B44","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s00296-012-2538-6","article-title":"Elevated serum high-sensitivity C-reactive protein levels in fibromyalgia syndrome patients correlate with body mass index, interleukin-6, interleukin-8, erythrocyte sedimentation rate","volume":"33","author":"Xiao","year":"2013","journal-title":"Rheumatol Int"},{"key":"2021061821282378500_keab146-B45","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3181\/0712-RM-328","article-title":"High plasma levels of MCP-1 and eotaxin provide evidence for an immunological basis of fibromyalgia","volume":"233","author":"Zhang","year":"2008","journal-title":"Exp Biol Med (Maywood)"},{"key":"2021061821282378500_keab146-B46","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/joim.12957","article-title":"Profiling of how nociceptor neurons detect danger\u2014new and old foes","volume":"286","author":"Crosson","year":"2019","journal-title":"J Int Med"},{"key":"2021061821282378500_keab146-B47","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","article-title":"Cellular and molecular mechanisms of pain","volume":"139","author":"Basbaum","year":"2009","journal-title":"Cell"},{"key":"2021061821282378500_keab146-B48","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.immuni.2017.06.008","article-title":"Mechanisms and therapeutic relevance of neuro-immune communication","volume":"46","author":"Chavan","year":"2017","journal-title":"Immunity"},{"key":"2021061821282378500_keab146-B49","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/nn1992","article-title":"The neuropathic pain triad: neurons, immune cells and glia","volume":"10","author":"Scholz","year":"2007","journal-title":"Nat Neurosci"},{"key":"2021061821282378500_keab146-B50","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1525-1403.2012.00462.x","article-title":"Spinal interleukin-10 therapy to treat peripheral neuropathic pain","volume":"15","author":"Milligan","year":"2012","journal-title":"Neuromodulation"},{"key":"2021061821282378500_keab146-B51","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12891-020-3154-3","article-title":"A systematic review of the role of inflammatory biomarkers in acute, subacute and chronic non-specific low back pain","volume":"21","author":"Morris","year":"2020","journal-title":"BMC Musculoskelet Disord"},{"key":"2021061821282378500_keab146-B52","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1523\/JNEUROSCI.3338-07.2008","article-title":"Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1\u03b2, interleukin-6, and tumor necrosis factor-\u03b1 in regulating synaptic and neuronal activity in the superficial spinal cord","volume":"28","author":"Kawasaki","year":"2008","journal-title":"J Neurosci"},{"key":"2021061821282378500_keab146-B53","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1046\/j.1471-4159.2001.00469.x","article-title":"The chemokine interleukin-8 acutely reduces Ca2+ currents in identified cholinergic septal neurons expressing CXCR1 and CXCR2 receptor mRNAs","volume":"78","author":"Puma","year":"2001","journal-title":"J Neurochem"},{"key":"2021061821282378500_keab146-B54","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ebiom.2019.04.032","article-title":"Interleukin-8 as a therapeutic target for chronic low back pain: upregulation in human cerebrospinal fluid and pre-clinical validation with chronic reparixin in the SPARC-null mouse model","volume":"43","author":"Krock","year":"2019","journal-title":"EBioMedicine"},{"key":"2021061821282378500_keab146-B55","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s11064-015-1521-5","article-title":"IL-10 and IL-1\u03b2 mediate neuropathic-pain like behavior in the ventrolateral orbital cortex","volume":"40","author":"Shao","year":"2015","journal-title":"Neurochem Res"},{"key":"2021061821282378500_keab146-B56","first-page":"2664","article-title":"Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain","volume":"54","author":"U\u00e7eyler","year":"2656","journal-title":"Arthritis Rheum"},{"key":"2021061821282378500_keab146-B57","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.pain.2005.09.026","article-title":"Increased levels of interstitial potassium but normal levels of muscle IL-6 and LDH in patients with trapezius myalgia","volume":"119","author":"Rosendal","year":"2005","journal-title":"Pain"},{"key":"2021061821282378500_keab146-B58","first-page":"146","article-title":"Detection of interleukin 1beta (IL-1beta), IL-6, and tumor necrosis factor-alpha in skin of patients with fibromyalgia","volume":"30","author":"Salemi","year":"2003","journal-title":"J Rheumatol"},{"key":"2021061821282378500_keab146-B59","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12883-014-0185-0","article-title":"Skin cytokine expression in patients with fibromyalgia syndrome is not different from controls","volume":"14","author":"\u00dc\u00e7eyler","year":"2014","journal-title":"BMC Neurol"},{"key":"2021061821282378500_keab146-B60","doi-asserted-by":"crossref","first-page":"13667","DOI":"10.1038\/s41598-019-49403-7","article-title":"No evidence for altered plasma NGF and BDNF levels in fibromyalgia patients","volume":"9","author":"Baumeister","year":"2019","journal-title":"Sci Rep"},{"key":"2021061821282378500_keab146-B61","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1468-2982.2005.01006.x","article-title":"Peripheral levels of BDNF and NGF in primary headaches","volume":"26","author":"Blandini","year":"2006","journal-title":"Cephalalgia"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab146\/36890108\/keab146.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/6\/2602\/38694900\/keab146.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/6\/2602\/38694900\/keab146.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T17:29:23Z","timestamp":1624037363000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/6\/2602\/6134095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,12]]},"references-count":62,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,2,12]]},"published-print":{"date-parts":[[2021,6,18]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab146","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,1]]},"published":{"date-parts":[[2021,2,12]]}}}